Ambit Care Logo
Learn About Rare Disease >    SLC13A5 Deficiency

SLC13A5 Deficiency

SLC13A5 deficiency is a rare genetic epilepsy characterized by seizures that start during the first few days of life and developmental delays.

Key characteristics and symptoms of SLC13A5 related disorders


Seizures: Patients present with seizures that often begin in the first few days of life, vary in type, and are persistent.

Developmental delay: Patients may experience speech, motor, and/or cognitive delays.


  • Movement problems
  • Speech impairment
  • Poor development of teeth

How is SLC13A5 deficiency diagnosed?

SLC13A5 deficiency is suspected based on symptoms but confirmed through genetic testing that identifies a mutation in both copies of the SLC13A5 gene.

How is SLC13A5 deficiency treated?

Currently there is no cure for SLC13A5 deficiency. Patients are treated for their symptoms, not for the underlying cause of the disease. Prescription medications and a variety of therapies help to alleviate symptoms. There are currently companies investigating treatments for SLC13A5 deficiency

AmbitCare can help you understand how rare disease might be part of your story.

The average person with a rare disease sees 7.3 specialists over a span of 5-7 years before receiving an accurate diagnosis. AmbitCare Ambassadors provide free services including listening to understand your challenges, guiding you on potential next steps, and recommending resources.

Join our community

Have additional questions? Contact an AmbitCare Ambassador by phone at 1-877-584-8995 or by email at today.

Our hours of operation are Monday-Friday, 9-5pm ET. An AmbitCare Ambassador will typically respond within 1-2 business days.

* Please note that while AmbitCare Ambassadors can help you better understand what resources are available for families with loved ones suffering from seizures and developmental delays, they are not licensed medical providers and thus can neither diagnose any disease or disorder nor endorse or recommend any specific medical treatments.